MedTrace Logo

Interstitial Brachytherapy Boost for Treatment of Anal Canal Cancers, Comparison of Two Dose Rates

NCT03465501 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 89

Last updated 2018-03-14

No results posted yet for this study

Summary

Comparative retrospective study of two anal canal brachytherapy techniques aimed at boosting \[low dose rate (LDR) and high dose rate (HDR)\]

Conditions

  • Anal Canal Cancer

Interventions

RADIATION

Brachytherapy

Brachytherapy

Sponsors & Collaborators

  • Institut Paoli-Calmettes

    lead OTHER

Principal Investigators

  • Leonel VARELA GAGETTI · Institut Paoli-Calmettes

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-17
Primary Completion
2016-07-28
Completion
2016-07-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03465501 on ClinicalTrials.gov